SC06, a novel small molecule compound, displays preclinical activity against multiple myeloma by disrupting the mTOR signaling pathway
Kunkun Han(Soochow University), Xinliang Mao(Guangzhou Medical University)
Cited by 21
Related Papers
The ubiquitin-activating enzyme E1 as a therapeutic target for the treatment of leukemia and multiple myeloma
|Blood|2010|168
Identification of a promising PI3K inhibitor for the treatment of multiple myeloma through the structural optimization
|Journal of Hematology & Oncology|2014|80
Clioquinol induces pro-death autophagy in leukemia and myeloma cells by disrupting the mTOR signaling pathway
|Scientific Reports|2014|67
The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival
|Journal of Biological Chemistry|2019|62
Suppression of the USP10/CCND1 axis induces glioblastoma cell apoptosis
|Acta Pharmacologica Sinica|2020|61